Authors
No takes yet. Share an insight, caveat, or question.
Network meta-analysis reveals combined bulevirtide and PEG-IFN-alpha improves virological outcomes in HDV patients.
Ouranos et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: